The IVF-stem cell interface – Public opinion and religious views matter  by Rizvi, Javed H. & Zuberi, Nadeem F.
Deceit and fraud in medical
research e Intermediary, commercially
based research teams are to blame
Dear Editor
The review by Jaffer and Cameron1 is timely. The
essence of good research is not only inspiration
but also adequate supervision. This extends in its
most basic form in writing a grant application to
day-to-day meetings with the researcher. With
the stripping of academic units on cost grounds,
there has been an increase in part-time academics
drawn from the clinical ranks and even a migration
of academics into ‘‘independent’’ clinical prac-
tice. The decreasing role of national bodies such
as the Medical Research Council and the parallel
increase in corporate sponsorship from multi-
national drug companies mitigate against effective
research governance.
Intermediary commercially based research
teams, in my view, can only increase risks of
both ethical and scientific mishap and their use
should be restricted. The recent tragedy at a North
London drug research centre whilst investigating
a monoclonal antibody based drug2, amply demon-
strates how loopholes in both ethics and research
process may occur. Statisticians remain the ‘‘cin-
derellas’’ of the research team and are frequently
denied their rightful place as co-authors on the fi-
nal paper. This could easily be remedied by editors
with good effect. I am not as pessimistic as Jaffer
and Cameron, but the welcome appearance of
well-funded top quality papers from Europe and
elsewhere will increase the spotlight on any per-
ceived weaknesses here in the UK.
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Letters to the Editor 133The IVF-stem cell interface e Public opinion
and religious views matterDear Editor
For a population of 140 million people in
Pakistan there are 5 centres providing tertiary
level facility of assisted conception to sub-fertile couples. Although IVF/ICSI is acceptable
to the couples, the financial burden associated
with it limits the utilization of this service. The
Pakistani population is predominantly Muslim
and is less flexible to any proposition which
134 Letters to the Editormay be considered as a deviation from the
principle doctrine of Islam.
It is well acknowledged by the stem cell re-
searchers that public opinion matters, and to
a significant extent people’s opinion is influenced
by their religious views. Currently, opinions of the
religious groups are divided on the issue of embry-
onic stem cell research. In Singapore, which is
a multi-racial, multi-religious and pluralistic soci-
ety, a survey1 conducted by Bioethics Advisory
Committee (BAC) of Singapore reported that the
religious groups of Muslims, Jews, Buddhists and
Hindus are in favour, and religious groups of Cath-
olic, Christian, Sikh and Taoist are against the em-
bryonic stem cell research. Therapeutic cloning
was favoured only by the Muslims and Buddhists.
As surrogate parenting or embryo adoption is
not permissible in Islam, Muslim scholars are in-
clined towards supporting the stem cell research.
In Pakistan there is a great need for recognizing
the importance of a platform to examine the
political, ethical, legal and social issues in light
of Islamic principles arising from research on the
IVF-stem cell interface. Furthermore, recommen-
dations are needed for making policies which are
acceptable to the masses.
doi:10.1016/j.ijsu.2006.04.002No matter how much accountability and trans-
parency is projected for the processes of informed
consent and good clinical practice, there always
remains the possibility of abuse. The greatest
danger is from the commercial agencies which
may exploit the possibilities of its therapeutic use.
A recent upsurge has also been seen in agencies
advertising preservation of cord blood for future
usage and for treating diseases.
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